LEADER 02042nam  2200373 a 450 
001 9910697175103321
005 20230902161605.0
035   $a(CKB)5470000002385159
035   $a(OCoLC)794684490
035   $a(EXLCZ)995470000002385159
100   $a20120604d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry, FDA staff, and FDA-accredited third parties$iManufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)$b[electronic resource]
210  1$a[Rockville, Md.] :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health ;$a[Bethesda, Md.] :$cCenter for Biologics Evaluation and Research,$d[2009]
215   $a1 online resource (10 pages)
300   $aTitle from PDF title screen (viewed May 24, 2012).
300   $a"Document issued on March 2, 2009."
300   $a"This document supercedes the document which was issued on September 15, 2005."
517 3 $aGuidance for industry, Food and Drug Administration staff, and Food and Drug Administration accredited third parties.
517 3 $aManufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)
606   $aMedical instruments and apparatus$xGovernment policy$zUnited States
615  0$aMedical instruments and apparatus$xGovernment policy
712 02$aCenter for Devices and Radiological Health (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697175103321
996   $aGuidance for industry, FDA staff, and FDA-accredited third parties$93467380
997   $aUNINA